Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000048

President & COO sold 27,097 shares at an average $16.27 ($440,801)

  • President & COO acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dowden Nathan J President & COO 2024-08-16 Option exercise 10b5-1 +20,000 $1.74 $34,800 157,204 D
Dowden Nathan J President & COO 2024-08-16 Sale 10b5-1 −26,595 $16.26 $432,419 130,609 D
Dowden Nathan J President & COO 2024-08-16 Sale 10b5-1 −502 $16.70 $8,382 130,107 D
Derivatives
Dowden Nathan J President & COO 2024-08-16 Option exercise · Stock Option (Right to Buy) 10b5-1 −20,000 64,831 D
Open-market sales · 27,097 sh · avg $16.27 · $440,801
Loading xslF345X05/wk-form4_1724186017.xml…